Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Spedding

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
Experimental Neurology|April 26, 2008
Protection of stress-induced impairment of hippocampal/prefrontal LTP through blockade of glucocorticoid receptors: implication of MEK signalingFrançois Mailliet, Hongshi Qi, Cyril Rocher, et al.
Neurotoxicity Research|January 2, 2007
Common efficacy of psychotropic drugs in restoring stress-induced impairment of prefrontal plasticityNathalie Dupin, François Mailliet, Cyril Rocher, et al.
Translational Psychiatry|February 19, 2020
Cognition- and circuit-based dysfunction in a mouse model of 22q11.2 microdeletion syndrome: effects of stressAnushree Tripathi, Michael Spedding, Esther Schenker, et al.
Neuropharmacology|September 4, 2010
Introduction to the special issue on High Resolution NeuropharmacologyGraham L Collingridge, Jean-Philippe Pin, Roderick E Hubbard, et al.
European Journal of Pharmacology|May 10, 2008
Agomelatine, a melatonin receptor agonist with 5-HT(2C) receptor antagonist properties, protects the developing murine white matter against excitotoxicityPierre Gressens, Leslie Schwendimann, Isabelle Husson, et al.
European Journal of Pharmacology|August 3, 2020
Drug repositioning in neurodegeneration: An overview of the use of ambroxol in neurodegenerative diseasesAlexandra Bouscary, Cyril Quessada, Frédérique René, et al.
Frontiers in Pharmacology|August 27, 2019
Ambroxol Hydrochloride Improves Motor Functions and Extends Survival in a Mouse Model of Familial Amyotrophic Lateral SclerosisAlexandra Bouscary, Cyril Quessada, Althéa Mosbach, et al.
Science (New York, N.Y.)|February 2, 2019
Plan S: A threat to quality of science?Michael Spedding, James Barrett, Edward T Morgan, et al.
Molecular Pharmacology|November 19, 2002
Mss4 gene is up-regulated in rat brain after chronic treatment with antidepressant and down-regulated when rats are anhedonicChristian Andriamampandry, Claude Muller, Catherine Schmidt-Mutter, et al.
Psychopharmacology|April 17, 2009
Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architectureAmandine Descamps, Colette Rousset, Mark J Millan, et al.
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
Experimental Neurology|April 26, 2008
Protection of stress-induced impairment of hippocampal/prefrontal LTP through blockade of glucocorticoid receptors: implication of MEK signalingFrançois Mailliet, Hongshi Qi, Cyril Rocher, et al.
Neurotoxicity Research|January 2, 2007
Common efficacy of psychotropic drugs in restoring stress-induced impairment of prefrontal plasticityNathalie Dupin, François Mailliet, Cyril Rocher, et al.
Translational Psychiatry|February 19, 2020
Cognition- and circuit-based dysfunction in a mouse model of 22q11.2 microdeletion syndrome: effects of stressAnushree Tripathi, Michael Spedding, Esther Schenker, et al.
Neuropharmacology|September 4, 2010
Introduction to the special issue on High Resolution NeuropharmacologyGraham L Collingridge, Jean-Philippe Pin, Roderick E Hubbard, et al.
European Journal of Pharmacology|May 10, 2008
Agomelatine, a melatonin receptor agonist with 5-HT(2C) receptor antagonist properties, protects the developing murine white matter against excitotoxicityPierre Gressens, Leslie Schwendimann, Isabelle Husson, et al.
European Journal of Pharmacology|August 3, 2020
Drug repositioning in neurodegeneration: An overview of the use of ambroxol in neurodegenerative diseasesAlexandra Bouscary, Cyril Quessada, Frédérique René, et al.
Frontiers in Pharmacology|August 27, 2019
Ambroxol Hydrochloride Improves Motor Functions and Extends Survival in a Mouse Model of Familial Amyotrophic Lateral SclerosisAlexandra Bouscary, Cyril Quessada, Althéa Mosbach, et al.
Science (New York, N.Y.)|February 2, 2019
Plan S: A threat to quality of science?Michael Spedding, James Barrett, Edward T Morgan, et al.
Molecular Pharmacology|November 19, 2002
Mss4 gene is up-regulated in rat brain after chronic treatment with antidepressant and down-regulated when rats are anhedonicChristian Andriamampandry, Claude Muller, Catherine Schmidt-Mutter, et al.
Psychopharmacology|April 17, 2009
Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architectureAmandine Descamps, Colette Rousset, Mark J Millan, et al.
Pageof 13